SCHEMBL7044950

SCHEMBL7044950

CCCC(=O)c1ccc(O)c(CCC)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.49
ALDH1A1 P00352 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
RECQL P46063 1/20 0.49
HSD17B10 Q99714 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
HSD17B3 P37058 1/20 0.42
HTT P42858 2/20 0.41
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
PRKCI P41743 1/20 0.40
IAPP P10997 2/20 0.39
TCF4 P15884 1/20 0.39
CTNNB1 P35222 1/20 0.39
CYP1A1 P04798 1/20 0.39
CYP1B1 Q16678 1/20 0.39
CYSLTR2 Q9NS75 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4017548 0.88 HSP90AB1 (0.49) HPGDALDH1A1HTTMEN1LMNA
SCHEMBL7968004 0.87 HTT (0.55) ALDH1A1HSD17B3HTTMEN1MAPT
SCHEMBL11393041 0.85 MAPT (0.40) HPGDALDH1A1HTTMEN1LMNA
SCHEMBL7042031 0.85 PIK3CA (0.38) HPGDALDH1A1ALOX15TSHRRECQL
SCHEMBL6933641 0.85 CYP1A1 (0.56) HPGDALDH1A1TSHRHTTMEN1
SCHEMBL30736074 0.82 CYP1A2 (0.50) ALDH1A1ALOX15TSHRTDP1MEN1
SCHEMBL480388 0.82 CYP1A2 (0.50) ALDH1A1ALOX15TSHRTDP1MEN1
SCHEMBL10726758 0.82 SELL (0.53) HPGDALDH1A1HSD17B10LMNAMAPT
SCHEMBL6102044 0.82 MEN1 (0.38) HPGDALDH1A1HTTMEN1LMNA
SCHEMBL6358047 0.82 GRM2 (0.46) HPGDHTTMEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP disclosed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US disclosed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 EP disclosed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed